High Tide Inc., founded in 2009, operates as Canada's largest cannabis retailer and its highest revenue-generating cannabis company. The company reported an annualized revenue run rate of approximately $600 million.
In mid-December, High Tide began positioning for potential expansion into the United States. This move coincided with White House actions toward rescheduling cannabis and announced plans to test Medicare coverage for CBD products.
Management indicated it is exploring licensing the Canna Cabana brand in the U.S. and developing CBD offerings aligned with Medicare frameworks. The company stated this could provide an early pathway into the world's largest cannabis-related market without immediate exposure to full federal legalization risks.
To support this growth phase, High Tide reengaged an investor relations firm to strengthen market communications. The company targets expanded opportunities across cannabis and CBD in both domestic and international markets.
The company further strengthened its leadership by expanding its Canna Cabana footprint to 218 stores. This deepened its national market share and rapidly growing loyalty base.
This scale helped propel the company to the $600 million annualized revenue run rate while supporting improved profitability. The company highlighted the operating leverage embedded in its retail-first, membership-driven model.
At the same time, High Tide took a step toward international diversification by entering Germany's medical cannabis market. This signaled ambitions extending beyond its Canadian core.